Sort by
Refine Your Search
-
unravel the complex relationships between land use changes and fire regimes over the past 60 years. The successful candidate will lead efforts to: Develop advanced deep learning algorithms for classifying
-
on analyzing experimental and time series data, applying crop and hydrologic modeling tools to improve understanding of soil, water, and plant interactions, and developing data-driven decision support tools
-
function following cervical spinal cord injury (SCI). The position involves conducting preclinical studies using rodent models to explore neuroplasticity-based therapies—such as therapeutic acute
-
ideally August 18, 2025. The project uses interdisciplinary methods from social network science, language modeling, and cognitive science. In this longitudinal project we will follow learners of Spanish who
-
clinical features using machine learning and foundational modeling approaches. This work supports disease modeling across chronic kidney disease, acute kidney injury, cancer, and neurological conditions. A
-
symptoms across the healthcare system, by integrating neuroimaging, psychophysiology, and computational modeling. Our work spans from basic science to clinical/translational neuroscience with humans, and our
-
, there are several exciting opportunities for a variety of very interesting projects beyond structure-function studies of cytoskeletal proteins that control signaling downstream of adherens junctions and focal
-
protostellar evolution models to radiative transfer grids. The goal is to synthesize these protostar models into protocluster models and compare them to JWST and ALMA data. The applicant must have a Ph.D. in
-
/ https://www.evansresearchgroup.org/ ) in the Department of Chemistry We have a position available in our groups to work on exploiting polymer topology to advance next-generation energy storage systems
-
structural elucidation, and (iii) synthetic chemistry and biocatalysis for the preparation and evaluation of antibody-drug conjugates (ADCs) as the next generation anticancer therapies by site-specific